Skip to collection list Skip to video grid
Skip to collection list Skip to video grid

Fetus/Newborn Infant

Utility of DAT in Low-Risk Neonates with ABO or RhD Incompatibility

Routine direct antiglobulin testing adds no predictive value beyond transcutaneous bilirubin monitoring for ABO or RhD incompatible neonates, supporting the discontinuation of universal screening.

Read More
Read Less

categories

View more in
Fetus/Newborn Infant

Currently loaded videos are 1 through 15 of 129 total videos.

First page loaded, no previous page available
Load Next Page